The DOI matches its Crossref record.
Presynaptic Nicotinic Modulation of Dopamine Release in the Three Ascending Pathways Studied by In Vivo Microdialysis: Comparison of Naive and Chronic Nicotine‐Treated Rats
Abstract
Abstract: The modulation of dopamine release by presynaptic nicotinic receptors in vitro is well established, but the significance of this effect in vivo is unclear. We have characterised the effect of nicotine, locally applied via a microdialysis probe, on dopamine release from the terminal regions of three ascending dopaminergic pathways in conscious, freely moving rats. Nicotine caused a dose‐dependent increase in dopamine release in the striatum, the nucleus accumbens, and, to a lesser extent, the frontal cortex. Metabolite levels were unaltered by any concentration of nicotine. Prior administration of mecamylamine via the probe abolished the nicotine‐evoked increase in dopamine release, confirming the mediation of nicotinic receptors. The dose dependence of mecamylamine‐sensitive, nicotine‐evoked dopamine release was similar in all three brain regions. However, 10−5M tetrodotoxin totally blocked nicotine‐stimulated dopamine release in the striatum and the accumbens but not the cortex. Daily subcutaneous injections of nicotine (0.4 mg kg−1 for 7 days) increased the response to a subsequent local application of nicotine in the striatum, and a similar trend was found in the other brain areas. The same daily dose of nicotine given as a continuous infusion had no effect, whereas infusion of 4 mg kg−1 day−1 increased the response to a subsequent nicotine challenge. The localisation and regulation of nicotinic receptors in the terminal fields of dopaminergic pathways are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These effects on dopaminergic terminals extend and confirm other reports that chronic nicotine increases nicotine-induced dopamine release (25,26) and upregulates receptors in striatum (5).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [25]
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Hilmas, C. J., Pereira, E. F. R., Alkondon, M., Rassoulpour, A., Schwarcz, R. M., & Albuquerque, E. X. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07463.2001 · Cited by 875
Neuronal nicotinic receptors in the human brain
Paterson, D., & Nordberg, A. K. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00045-3 · Cited by 792
Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum
Zhou, F.-M., Liang, Y., & Dani, J. A. (2001) · Nature Neuroscience · doi:10.1038/nn769 · Cited by 585
PRESYNAPTIC IONOTROPIC RECEPTORS AND THE CONTROL OF TRANSMITTER RELEASE
MacDermott, A. B., Role, L. W., & Siegelbaum, S. A. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.443 · Cited by 570
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 569
Cachope, R., Mateo, Y., Mathur, B. N., Irving, J. M., Wang, H., Morales, M., Lovinger, D. M., & Cheer, J. F. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.05.011 · Cited by 529
Logue, S. F., & Gould, T. J. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.08.007 · Cited by 477
Effect of nicotine and nicotinic receptors on anxiety and depression
Picciotto, M. R., Brunzell, D. H., & Caldarone, B. J. (2002) · Neuroreport · doi:10.1097/00001756-200207020-00006 · Cited by 483
Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal
S. Watkins, G. F. K. (2000) · Nicotine & Tobacco Research · doi:10.1080/14622200050011277 · Cited by 424
Nicotinic receptors in the brain. Links between molecular biology and behavior
Picciotto, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00146-3 · Cited by 354
Presynaptic Recording of Quanta from Midbrain Dopamine Neurons and Modulation of the Quantal Size
Pothos, E. N., Davila, V., & Sulzer, D. L. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-11-04106.1998 · Cited by 320
Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans
Volkow, N. D., Fowler, J. S., & Wang, G.-J. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300406 · Cited by 315
Shi, Y., Weingarten, T. N., Mantilla, C. B., Hooten, W. M., & Warner, D. O. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181ebdaf9 · Cited by 315
Vanderschuren, L. J. M. J., Schmidt, E. D., Vries, T. J. D., Moorsel, C. A. P. V., Tilders, F. J. H., & Schoffelmeer, A. N. M. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09579.1999 · Cited by 286
Acetylcholine–Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders
Lester, D. B., Rogers, T. D., & Blaha, C. D. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00142.x · Cited by 267
The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum
Grady, S. R., Salminen, O., Laverty, D. C., Whiteaker, P., McIntosh, J. M., Collins, A. C., & Marks, M. J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.032 · Cited by 252
GABAB receptor agonists for the treatment of drug addiction: a review of recent findings
Cousins, M. S., Roberts, D. C. S., & de Wit, H. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00163-6 · Cited by 240
Behavioral disinhibition requires dopamine receptor activation
van Gaalen, M. M., Brueggeman, R. J., Bronius, P. F. C., Schoffelmeer, A. N. M., & Vanderschuren, L. J. M. J. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0396-1 · Cited by 240
Presynaptic ionotropic receptors and control of transmitter release
Engelman, H. S., & MacDermott, A. B. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1297 · Cited by 230
Vizi, E. S., & Lendvai, B. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00016-8 · Cited by 228
Kaiser, S., & Wonnacott, S. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.2.312 · Cited by 218
Self-citationSchilström, B., Svensson, H. M., Svensson, T. H., & Nomikos, G. G. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00114-6 · Cited by 207
Unconventional ligands and modulators of nicotinic receptors
Pereira, E. F. R., Hilmas, C. J., Santos, M. D., Alkondon, M., Maelicke, A., & Albuquerque, E. X. (2002) · Journal of Neurobiology · doi:10.1002/neu.10146 · Cited by 202
Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders
Sacco, K. A., Bannon, K. L., & George, T. P. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104047273 · Cited by 203
α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson’s Disease
Quik, M., & Wonnacott, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003269 · Cited by 201
Self-citationGioanni, Y., Rougeot, C., Clarke, P. B. S., Lepousé, C., Thierry, A. M., & Vidal, C. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00403.x · Cited by 191
Ryan, R. E., Ross, S. A., Drago, J., & Loiacono, R. E. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703989 · Cited by 188
Wang, F., Nelson, M. E., Kuryatov, A., Olale, F., Cooper, J., Keyser, K., & Lindstrom, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.28721 · Cited by 187
Tizabi, Y., Copeland, R., Louis, V. A., & Taylor, R. E. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02551.x · Cited by 180
Nicotinic receptors in human brain: topography and pathology
Court, J. A., Martin-Ruiz, C., Graham, A., & Perry, E. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00110-1 · Cited by 180
Potter, A., & NEWHOUSE, P. A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1874-y · Cited by 184
Current pharmacological treatments for nicotine dependence
George, T. P., & O’Malley, S. S. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.11.003 · Cited by 179
Labarca, C., Schwarz, J., Deshpande, P., Schwarz, S., Nowak, M. W., Fonck, C., Nashmi, R., Kofuji, P., Dang, H., Shi, W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041582598 · Cited by 177
Carboni, E., Silvagni, A., Rolando, M. T. P., & Chiara, G. D. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-20-j0002.2000 · Cited by 173
Potter, A., & NEWHOUSE, P. A. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.09.014 · Cited by 168
Lester, H. A., Xiao, C., Srinivasan, R., Son, C. D., Miwa, J., Pantoja, R., Banghart, M. R., Dougherty, D. A., Goate, A. M., & Wang, J. C. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9090-7 · Cited by 163
Psychostimulant-Induced Behavioral Sensitization Depends on Nicotinic Receptor Activation
Schoffelmeer, A. N. M., Vries, T. J. D., Wardeh, G., van de Ven, H. W. M., & Vanderschuren, L. J. M. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03269.2002 · Cited by 159
Collins, S. L., & Izenwasser, S. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.024 · Cited by 156
Vanderschuren, L. J. M. J., Vries, T. J. D., Wardeh, G., Hogenboom, F., & Schoffelmeer, A. N. M. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01775.x · Cited by 147
Court, J. A., Lloyd, S., Thomas, N., Piggott, M. A., Marshall, E. F., Morris, C. M., Lamb, H., Perry, R. H., Johnson, M., & Perry, E. K. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00088-8 · Cited by 135
Nicotinic acetylcholine receptors and the ascending dopamine pathways
Livingstone, P. D., & Wonnacott, S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.004 · Cited by 139
Self-citationFerrari, R., Le Novère, N., Picciotto, M. R., Changeux, J. P., & Zoli, M. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2001.02009.x · Cited by 132
Picard, F., Bertrand, S., Steinlein, O. K., & Bertrand, D. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00848.x · Cited by 131
Prefrontal cortical modulation of acetylcholine release in posterior parietal cortex
Nelson, C. L., Sarter, M., & Bruno, J. P. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.12.007 · Cited by 128
Nicotine and Nicotinic Receptors; Relevance to Parkinson’s Disease
Quik, M., & Kulak, J. M. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00036-0 · Cited by 129
Sex Differences in Nicotine Action
Pöğün, Ş., & Yararbaş, G. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_10 · Cited by 127
Neurobiological Mechanisms of Nicotine Reward and Aversion
Wills, L. P., Ables, J. L., Braunscheidel, K. M., Caligiuri, S. P. B., Elayouby, K. S., Fillinger, C., Ishikawa, M., Moen, J. K., & Kenny, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000299 · Cited by 134
Cholinergic Drugs for Alzheimer's Disease Enhance in Vitro Dopamine Release
Zhang, L., Zhou, F.-M., & Dani, J. A. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000299 · Cited by 122
Cholinergic connectivity: it's implications for psychiatric disorders
Scarr, E., Gibbons, A. S., Neo, J. H., Udawela, M., & Dean, B. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00055 · Cited by 124
Common aspects of the action of nicotine and other drugs of abuse
Picciotto, M. R. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00074-x · Cited by 117
Xiao, C., Nashmi, R., McKinney, S. L., Cai, H., McIntosh, J. M., & Lester, H. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2939-09.2009 · Cited by 117
Transdermal nicotine alters some of marihuana's effects in male and female volunteers
Penetar, D. M., Kouri, E. M., Gross, M. M., McCarthy, E. M., Rhee, C. K., Peters, E. N., & Lukas, S. E. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.01.008 · Cited by 115
Vulnerability of125I-α-Conotoxin MII Binding Sites to Nigrostriatal Damage in Monkey
Quik, M., Polonskaya, Y., Kulak, J. M., & McIntosh, J. M. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05494.2001 · Cited by 109
Grady, S. R., Murphy, K. L., Cao, J., Marks, M. J., McIntosh, J. M., & Collins, A. C. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.651 · Cited by 110
Mathieu-Kia, A.-M., & Besson, M. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00338-0 · Cited by 108
Molecular and Cellular Mechanisms of Action of Nicotine in the CNS
Barik, J., & Wonnacott, S. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_7 · Cited by 112
Self-citationDopamine in the hippocampus is cleared by the norepinephrine transporter
Borgkvist, A., Malmlöf, T., Feltmann, K., Lindskog, M., & Schilström, B. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000812 · Cited by 102
Molander, A., & S�derpalm, B. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000150012.09608.81 · Cited by 101
Shim, I., Javaid, J. I., Wirtshafter, D., Jang, S.-Y., Shin, K.-H., Lee, H., Chung, Y.-C., & Chun, B. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00161-9 · Cited by 103
Wouda, J. A., Riga, D., de Vries, W., Stegeman, M., van Mourik, Y., Schetters, D., Schoffelmeer, A. N. M., Pattij, T., & Vries, T. J. D. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2213-8 · Cited by 99
Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders
Sacco, K. A., Bannon, K. L., & George, T. P. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800403 · Cited by 100
Wing, V. C., Wass, C., Soh, D. W., & George, T. P. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06261.x · Cited by 99
The effect of nicotine on striatal dopamine release in man: A [11C]raclopride PET study
Montgomery, A. J., Lingford-Hughes, A. R., Egerton, A., Nutt, D., & Grasby, P. M. (2007) · Synapse · doi:10.1002/syn.20419 · Cited by 93
Involvement of Accumbal Glycine Receptors in the Regulation of Voluntary Ethanol Intake in the Rat
Molander, A., L??f, E., Stomberg, R., Ericson, M., & S�derpalm, B. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000150009.78622.e0 · Cited by 93
Tsukada, H., Miyasato, K., Kakiuchi, T., Nishiyama, S., Harada, N., & Domino, E. F. (2002) · Synapse · doi:10.1002/syn.10102 · Cited by 91
Glycine Receptors Regulate Dopamine Release in the Rat Nucleus Accumbens
Molander, A., & S�derpalm, B. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000150006.17168.f7 · Cited by 92
Quik, M., Sum, J., Whiteaker, P., McCallum, S. E., Marks, M. J., Musachio, J. L., McIntosh, J. M., Collins, A. C., & Grady, S. R. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1169 · Cited by 86
Nguyen, H. N., Rasmussen, B. A., & Perry, D. C. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02482.x · Cited by 83
Wang, J., & Li, M. D. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.178 · Cited by 84
CB1 Receptor Antagonism Increases Hippocampal Acetylcholine Release: Site and Mechanism of Action
Degroot, A., Köfalvi, A., Wade, M. R., Davis, R. J., Rodrigues, R. J., Rebola, N., Cunha, R. A., & Nomikos, G. G. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.024661 · Cited by 82
Nicotine and endogenous opioids: neurochemical and pharmacological evidence
Hadjiconstantinou, M., & Neff, N. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.010 · Cited by 81
Janhunen, S. K., & Ahtee, L. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.09.008 · Cited by 83
Salminen, O., Seppä, T., Gäddnäs, H., & Ahtee, L. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-18-08145.1999 · Cited by 80
Quarta, D., Ciruela, F., Patkar, K. A., Borycz, J., Solinas, M., Lluı́s, C., Franco, R., Wise, R. A., Goldberg, S. R., Hope, B. T., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301103 · Cited by 80
Fedele, E., Varnier, G., Ansaldo, M. A., & Raiteri, M. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702130 · Cited by 79
Nicotine-induced Attentional Enhancement in Rats Effects of Chronic Exposure to Nicotine
Hahn, B. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00348-2 · Cited by 78
A Critique of the Dopamine Hypothesis of Schizophrenia and Psychosis
Moncrieff, J. (2009) · Harvard Review of Psychiatry · doi:10.1080/10673220902979896 · Cited by 83
Perez, X. A., Bordia, T., McIntosh, J. M., Grady, S. R., & Quik, M. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.048843 · Cited by 77
Smoking Cessation and Chronic Pain: Patient and Pain Medicine Physician Attitudes
Hooten, W., Vickers, K. S., Shi, Y., Ebnet, K. L., Townsend, C. O., Patten, C., & Warner, D. O. (2011) · Pain Practice · doi:10.1111/j.1533-2500.2011.00462.x · Cited by 73
Gozzi, A., Schwarz, A. J., Reese, T., Bertani, S., Crestan, V., & Bifone, A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300955 · Cited by 77
Matteo, V. D., Pierucci, M., & Esposito, E. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02337.x · Cited by 78
Rahman, S., & McBride, W. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00739.x · Cited by 75
Shoaib, M., Schindler, C. W., Goldberg, S. R., & Pauly, J. R. (1997) · Psychopharmacology · doi:10.1007/s002130050433 · Cited by 72
Reinforcement enhancing effect of nicotine and its attenuation by nicotinic antagonists in rats
Liu, X., Palmatier, M. I., Caggiula, A. R., Donny, E. C., & Sved, A. F. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0863-3 · Cited by 78
Plant Toxins That Affect Nicotinic Acetylcholine Receptors: A Review
Green, B. T., Welch, K. D., Panter, K. E., & Lee, S. T. (2013) · Chemical Research in Toxicology · doi:10.1021/tx400166f · Cited by 66
Grilli, M., Parodi, M., Raiteri, M., & Marchi, M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03126.x · Cited by 65
Fu, Y., Matta, S. G., Gao, W., & Sharp, B. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00371-7 · Cited by 64
Liu, X., Jernigen, C., Gharib, M. A., Booth, S., Caggiula, A. R., & Sved, A. F. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328337be95 · Cited by 61
Addiction‐related neuroadaptations following chronic nicotine exposure
Wills, L., & Kenny, P. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15356 · Cited by 61
Dimpfel, W. (2008) · Neuropsychobiology · doi:10.1159/000191124 · Cited by 64
Marchi, M., & Grilli, M. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.004 · Cited by 61
Rahman, S., Zhang, J., & Corrigall, W. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00723-7 · Cited by 59
Receptor systems participating in nicotine-specific effects
Sziráki, I., Sershen, H. W., Benuck, M., Hashim, A., & Lajtha, Á. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(98)00049-7 · Cited by 58
The effect of nicotine on developing brain catecholamine systems
Heather, S. (1999) · Frontiers in bioscience · doi:10.2741/oliff · Cited by 67
Meshul, C. K., Kamel, D., Moore, C., Kay, T. S., & Krentz, L. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7900 · Cited by 57
Ueno, K., Togashi, H., Matsumoto, M., Ohashi, S., Saito, H., & Yoshioka, M. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.95 · Cited by 56
Caffeine and amphetamine produce cross-sensitization to nicotine-induced locomotor activity in mice
Celik, E., Uzbay, T. I., & Karakaş, S. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.06.014 · Cited by 58
Chronic nicotine administration in the drinking water affects the striatal dopamine in mice
Pietilä, K., & Ahtee, L. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00235-5 · Cited by 50
Coura, R. S., Cressant, A., Xia, J., de Chaumont, F., Olivo‐Marin, J. C., Pelloux, Y., Dalley, J. W., & Granon, S. (2013) · The FASEB Journal · doi:10.1096/fj.13-231084 · Cited by 33
Visanji, N. P., Mitchell, S. N., O'Neill, M. J., & Duty, S. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.07.013 · Cited by 25
Metadata
- Authors
- Marshall, D. L., Redfern, P. H., & Wonnacott, S.
- Affiliations
- University of Bath (GB)
- Corresponding author
- Wonnacott, Susan
- ORCID
- Wonnacott, Susan
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 1997-04
- Volume
- 68
- Issue
- 4
- Pages
- 1511-1519
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2090796082
- Cited by
- 284
- References
- 0
- Citations by year
- 2025: 1 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 7 · 2018: 8 · 2017: 1 · 2016: 7 · 2015: 9 · 2014: 3 · 2013: 13 · 2012: 10
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- presynaptic nicotinic acetylcholine receptors, dopamine release, nicotine, striatum, nucleus accumbens, frontal cortex, mecamylamine, tetrodotoxin, chronic nicotine treatment, nicotine tolerance, dopamine metabolites, in vivo microdialysis
- MeSH terms
- Animals, Dopamine, Male, Mecamylamine, Neurons, Nicotine, Tetrodotoxin, Time Factors, Rats, Sprague-Dawley, Microdialysis, Presynaptic Terminals, Nicotinic Agonists, Nicotinic Antagonists, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review